CDNAF(CDNAF)
CDNAF
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $16.62B | $17.06B | $17.60B |
| Low | $16.41B | $16.68B | $17.29B |
| High | $16.96B | $17.81B | $18.17B |
| EBITDA Avg | $2.13B | $2.19B | $2.25B |
| Low | $2.10B | $2.14B | $2.21B |
| High | $2.17B | $2.28B | $2.33B |
| EBIT Avg | $1.37B | $1.41B | $1.45B |
| Low | $1.36B | $1.38B | $1.43B |
| High | $1.40B | $1.47B | $1.50B |
| Net Income Avg | $792M | $866M | $1.01B |
| Low | $774M | $846M | $985M |
| High | $825M | $902M | $1.05B |
| EPS Avg | $14.54 | $15.90 | $18.51 |
| Low | $14.21 | $15.54 | $18.09 |
| High | $15.15 | $16.57 | $19.29 |
| Analysts (Rev / EPS) | 9 / 1 | 9 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $4.24B | $4.45B | $3.59B | $4.37B | $4.34B | $4.71B |
| Low | $4.20B | $4.41B | $3.56B | $4.33B | $4.30B | $4.66B |
| High | $4.29B | $4.51B | $3.64B | $4.43B | $4.40B | $4.77B |
| EBITDA Avg | $543M | $571M | $460M | $560M | $557M | $603M |
| Low | $538M | $565M | $455M | $555M | $551M | $597M |
| High | $550M | $578M | $466M | $568M | $564M | $611M |
| EBIT Avg | $350M | $368M | $297M | $361M | $359M | $389M |
| Low | $346M | $364M | $294M | $358M | $355M | $385M |
| High | $355M | $372M | $300M | $366M | $363M | $394M |
| Net Income Avg | $212M | $238M | $113M | $233M | $228M | $261M |
| Low | $209M | $235M | $111M | $230M | $225M | $258M |
| High | $215M | $242M | $115M | $236M | $232M | $266M |
| EPS Avg | $4.00 | $4.50 | $2.13 | $4.39 | $4.31 | $4.93 |
| Low | $3.95 | $4.44 | $2.10 | $4.33 | $4.25 | $4.87 |
| High | $4.06 | $4.58 | $2.17 | $4.46 | $4.38 | $5.02 |
| Analysts (Rev / EPS) | 5 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 |